The role of visfatin in the pathogenesis of gestational diabetes mellitus

Journal of Endocrinological Investigation

Volumn 34, Issue 1, 2011, Pages 3-7

  Gok, Deniz Engin ^a   Yazici, M ^a   Uckaya, G ^a   Bolu, S E ^a   Basaran, Y ^a   Ozgurtas, T ^a   Kilic, S ^a   Kutlu, M ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Gestational diabetes mellitus; Post partum; Pregnancy; Visfatin

Indexed keywords

NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; HUMAN; INFLAMMATION; LIPID METABOLISM; PATHOGENESIS; PREGNANCY DIABETES MELLITUS;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; CYTOKINES; DELIVERY, OBSTETRIC; DIABETES, GESTATIONAL; FEMALE; GESTATIONAL AGE; GLUCOSE TOLERANCE TEST; HUMANS; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; POSTPARTUM PERIOD; PREGNANCY;

EID: 79955384755     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/6902     Document Type: Article

References (13)

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2008, 31 (Suppl 1): 55-60.
2. Krzyzanowska K, Krugluger W, Mittermayer F, et al. Increased Visfatin visfatin concentrations in women with gestational diabetes mellitus. Clin Sci (Lond) 2006, 110: 605-9. (Pubitemid 43736123)
3. Chen MP, Chung FM, Chang DM, et al. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2006, 91: 295-9.
4. Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005, 307: 426-30. (Pubitemid 40139988)
5. Chan TF, Chen YL, Lee CH, et al. Decreased plasma visfatin concentrations in women with gestational diabetes mellitus. J Soc Gynecol Investig 2006, 13: 364-7.
6. Haider DG, Handisurya A, Storka A, et al. Visfatin response to glucose is reduced in women with gestational diabetes mellitus. Diabetes Care 2007, 30: 1889-91. (Pubitemid 47036375)
7. Szamatowicz J, Kuzmicki M, Telejko B, et al. Serum visfatin concentration is elevated in pregnant women irrespectively of the presence of gestational diabetes. Ginekol Pol 2009, 80: 14-8.
8. American Diabetes Association. Clinical practice recommendations. Gestational diabetes mellitus. Diabetes Care 2002, 25 (Suppl 1): 94-6.
9. Matthews DR, Hasker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in men. Diabetologia 1985, 28: 412-9. (Pubitemid 15018832)
10. Di Cianni G, Seghieri G, Lencioni C, et al. Normal glucose tolerance and gestational diabetes mellitus: what is in between?. Diabetes Care 2007, 30: 1783-8. (Pubitemid 47036352)
11. Lewandowski KC, Stojanovic N, Press M, et al. Elevated serum levels of visfatin in gestational diabetes: a comparative study across various degrees of glucose tolerance. Diabetologia 2007, 50: 1033-7. (Pubitemid 46559248)
12. Mastorakos G, Valsamakis G, Papatheodorou DC, et al. The role of adipocytokines in insulin resistance in normal pregnancy: visfatin concentrations in early pregnancy predict insulin sensitivity. Clin Chem 2007, 53: 1477-83. (Pubitemid 47206344)
13. Akturk M, Altinova AE, Mert I, et al. Visfatin concentration is decreased in women with gestational diabetes mellitus in the third trimester. J Endocrinol Invest 2008, 31: 610-3.